STOCK TITAN

Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Vanda Pharmaceuticals will participate in the Jefferies 2024 Global Healthcare Conference in New York City on June 6, 2024. The company will deliver a corporate presentation at 2:00 p.m. ET, accessible live on Vanda's corporate website. Investors can register and view the presentation by clicking on the Investors tab and following the link under Recent Events. A recording of the presentation will be available on the website for 30 days post-conference.

Positive
  • Vanda Pharmaceuticals' participation in a major healthcare conference may increase visibility and interest among investors.
  • The live-streamed corporate presentation provides an opportunity for real-time engagement with investors.
Negative
  • No immediate financial or clinical outcome is guaranteed from participation in the conference.
  • The impact of the presentation is to investor engagement, with no direct business expansion or revenue growth indicated.

WASHINGTON, May 30, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Jefferies 2024 Global Healthcare Conference in New York City on Thursday, June 6, 2024. A corporate presentation is scheduled for 2:00 p.m. Eastern Time.

The corporate presentation given at the Jefferies 2024 Global Healthcare Conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-jefferies-2024-global-healthcare-conference-302160029.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

When is Vanda Pharmaceuticals presenting at the Jefferies 2024 Global Healthcare Conference?

Vanda Pharmaceuticals is presenting on June 6, 2024, at 2:00 p.m. Eastern Time.

How can I access Vanda Pharmaceuticals' presentation at the Jefferies 2024 Global Healthcare Conference?

You can access the presentation live on Vanda's corporate website under the Investors tab in the Recent Events section.

Will the Vanda Pharmaceuticals' presentation at the Jefferies 2024 Global Healthcare Conference be available after the event?

Yes, a link to the archived presentation will be available on Vanda's website for approximately 30 days after the conference.

What is Vanda Pharmaceuticals' stock symbol?

Vanda Pharmaceuticals' stock symbol is VNDA.

What is the main purpose of Vanda Pharmaceuticals participating in the Jefferies 2024 Global Healthcare Conference?

The main purpose is to increase visibility and engage with investors through a corporate presentation.

Vanda Pharmaceuticals Inc.

NASDAQ:VNDA

VNDA Rankings

VNDA Latest News

VNDA Stock Data

274.63M
56.47M
3.15%
78.43%
5.53%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WASHINGTON